Largest biotech companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 17 biotech companies in the United States ranked by revenue, at DKK 250.4B, ahead of Gilead Sciences (DKK 200.6B) and Biogen (DKK 67.4B). Figures as of 21 Nov 2026, 00:42 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 17
- First
- AmgenDKK 250.4B
- Median
- DKK 5B
- Combined market value
- DKK 4.96T
- Countries
- 1
- Not ranked
- 3no revenue on file
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | DKK 250.4B | DKK 1.61T | DKK 2,968.54 | 0.15% down | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | DKK 200.6B | DKK 1.41T | DKK 1,134.09 | 0.06% down | 31% up | ||
| 3 | BiogenBIIB · Health Care | DKK 67.4B | DKK 251.4B | DKK 1,700.76 | 1.00% up | 41% up | ||
| 4 | Neurocrine BiosciencesNBIX · Health Care | DKK 19.5B | DKK 103.9B | DKK 1,026.01 | 3.84% down | 10% up | ||
| 5 | ExelixisEXEL · Health Care | DKK 15.8B | DKK 107.5B | DKK 440.40 | 1.82% down | 55% up | ||
| 6 | ModernaMRNA · Health Care | DKK 13.2B | DKK 537.6B | DKK 1,328.77 | 2.17% down | 740% up | ||
| 7 | Halozyme TherapeuticsHALO · Health Care | DKK 9.5B | DKK 71B | DKK 622.48 | 1.82% down | 32% up | ||
| 8 | Bio-TechneTECH · Health Care | DKK 8.3B | DKK 77.8B | DKK 495.19 | 0.04% down | 18% up | ||
| 9 | RepligenRGEN · Health Care | DKK 5B | DKK 71.4B | DKK 1,116.23 | 3.81% down | 5% up | ||
| 10 | Krystal BiotechKRYS · Health Care | DKK 2.7B | DKK 62.4B | DKK 2,104.84 | 2.19% down | 49% up | ||
| 11 | Twist BioscienceTWST · Health Care | DKK 2.6B | DKK 48B | DKK 704.04 | 7.44% down | 291% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | DKK 1.9B | DKK 30.8B | DKK 190.32 | 0.43% down | 51% up | ||
| 13 | ImmunityBioIBRX · Health Care | DKK 772M | DKK 43.6B | DKK 41.02 | 8.37% down | 216% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | DKK 267.2M | DKK 67.1B | DKK 785.75 | 3.42% down | 81% up | ||
| 15 | CG OncologyCGON · Health Care | DKK 27.5M | DKK 48.4B | DKK 541.52 | 2.97% down | 93% up | ||
| 16 | Revolution MedicinesRVMD · Health Care | DKK 0 | DKK 237.6B | DKK 1,098.45 | 1.11% up | 125% up | ||
| 17 | Scholar Rock HoldingSRRK · Health Care | DKK 0 | DKK 40B | DKK 327.97 | 4.45% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8142 DKK). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech companies in the United States rank first by revenue?
Amgen (DKK 250.4B), Gilead Sciences (DKK 200.6B) and Biogen (DKK 67.4B) are the top three of the 17 biotech companies in the United States ranked by revenue as of 21 Nov 2026, 00:42 UTC.
How many biotech companies in the United States are in this ranking?
17 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech companies in the United States worth together?
The 17 biotech companies in the United States ranked by revenue have a combined market value of DKK 4.96T as of 21 Nov 2026, 00:42 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies in the United States by revenue”, data as of 21 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.